Related Experiment Video
Updated: May 15, 2026

04:47
A Model for Experimental Exposure of Humans to Larval Ixodes scapularis Ticks
Published on: December 1, 2023
Vaccination and tick-borne encephalitis, central Europe
Franz X Heinz1, Karin Stiasny, Heidemarie Holzmann
1Department of Virology, Medical University of Vienna, Vienna, Austria. franz.x.heinz@meduniwien.ac.at
Emerging Infectious Diseases
|December 25, 2012
Summary
Mass vaccination against tick-borne encephalitis (TBE) significantly reduced TBE incidence in Austria. The TBE vaccine proved effective across all age groups, preventing thousands of cases.
Area of Science:
- Epidemiology
- Public Health
- Vaccinology
Background:
- Tick-borne encephalitis (TBE) poses a significant public health challenge in endemic regions of Europe and Asia.
- Understanding the impact of vaccination programs is crucial for disease control.
Purpose of the Study:
- To evaluate the long-term effect of increased TBE vaccination coverage in Austria.
- To compare TBE incidence trends in Austria with other highly endemic Central European countries.
Main Methods:
- Comparative analysis of TBE incidence rates over 40 years in Austria, the Czech Republic, and Slovenia.
- Assessment of age distribution shifts in TBE patient populations.
- Estimation of TBE cases prevented by vaccination in Austria.
Main Results:
- Austria experienced a substantial decrease in TBE incidence, reaching approximately 16% of pre-vaccination levels.
- High incidence rates persisted in unvaccinated populations.
- The TBE vaccine demonstrated effectiveness across all age demographics.
- An estimated 4,000 TBE cases were prevented in Austria between 2000 and 2011.
Conclusions:
- Mass TBE vaccination campaigns are highly effective in reducing disease incidence.
- Sustained high incidence in unvaccinated groups highlights the importance of continued vaccination efforts.
- TBE vaccination is a critical public health intervention for endemic areas.
Related Concept Videos
Arboviral Encephalitis
Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...
Encephalitis l: Introduction
Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Vaccinations
Overview
Encephalitis ll: Pathophysiology
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...

